Heterocyclic compound
US9388195B2 · kind B2 · utility
0Cited by
6References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 10, 2014 |
| Grant date | Jul 12, 2016 |
| Priority date | — |
| Expiry date | Dec 10, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided is a compound useful for the prophylaxis or treatment of cancer.The present invention relates to a compound represented by formula (I):wherein each symbol in the formula is as defined in the specification, or a salt thereof or a prodrug thereof, which is useful for the prophylaxis or treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.